PharmaCentra Interviews Peter J. Pitts, President of the Center for Medicine in the Public Interest

Dan Berman, CEO of PharmaCentra, Concentra Solutions, and CannabisBPO discusses the COVID-19 Emergency Use Authorization (EUA) for vaccines in children over 12 years old with Peter J. Pitts, President of the Center for Medicine in the Public Interest, Former FDA Associate Commissioner.

PharmaCentra delivers unique, customizable marketing and communications programs for pharmaceutical and insurance providers to communicate more effectively with patients, healthcare providers and pharmacies. PharmaCentra is a 24/7 multilingual contact center provider with operations in the US and Canada. Peter Pitts is President of the Center for Medicine in the Public Interest and Chief Regulatory Officer at Adherent Health Strategies. A former member of the United States Senior Executive Service, Peter was FDA’s Associate Commissioner for External Relations, serving as senior communications and policy adviser to the Commissioner.

Follow Us on Social Media for Updates:

LinkedIn – https://linkedin.com/company/pharmace…

Facebook – https://www.facebook.com/pharmacentra

Twitter – https://twitter.com/pharmacentra

Instagram – https://www.instagram.com/pharmacentra/